Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Cross entropy gradient analysis for Alzheimer's disease assessment
Aldo Camargo1, Gianpaolo Del Mauro1, Ze Wang1,2
1Department of Diagnostic Radiology & Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Abstract:
BackgroundAlzheimer's disease (AD) involves progressive cognitive decline associated with disrupted coordination and information exchange across brain regions. Cross-entropy can characterize inter-regional information flow, but its role in AD remains unexplored.ObjectiveTo evaluate cross-regional brain entropy (CRBEN) derived from resting-state fMRI in normal controls (NC), mild cognitive impairment (MCI), and AD, and to assess its potential as a biomarker of disease progression.MethodsResting-state fMRI data from 40 NC, 38 MCI, and 40 AD participants from ADNI 2/3 were preprocessed using SPM12 and FSL, including motion correction (FD < 0.5 mm). Mean time series were extracted from 300 regions of the seven-network Schaefer atlas. For each subject, a 300 × 300 CRBEN matrix was computed and decomposed using BrainSpace to obtain functional gradients, aligned via Procrustes analysis. Group differences were tested with two-sample t-tests controlling for age, sex, and education (Bonferroni-corrected, α = 0.05). Machine-learning classifiers were trained using gradient and demographic features, with robustness assessed by 1000 bootstrap resamples.ResultsCompared with NC, MCI showed reduced gradients in somatomotor, ventral-attention, and default-mode networks. AD showed further reductions versus MCI in somatomotor and default-mode networks, and versus NC in frontoparietal-control and default-mode networks (p < 0.05, corrected). Logistic regression achieved the highest accuracy (∼90%). Gradient flattening was prominent in temporal and occipital cortices, indicating reduced hierarchical organization.ConclusionsCRBEN gradients demonstrate progressive loss of network complexity across the AD continuum and may provide sensitive biomarkers of functional disintegration.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment

